Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (16)

2024

  1. Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference

    European Journal of Internal Medicine, Vol. 124, pp. 54-60

  2. Epicardial and liver fat implications in albuminuria: a retrospective study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  3. Revisiting the beyond BMI paradigm in excess weight diagnosis and management: A call to action

    European Journal of Clinical Investigation, Vol. 54, Núm. 7

2023

  1. Antidiabetic Drugs That Reduce Weight and Are Cardioprotective

    Handbook of Obesity - Volume 2: Clinical Applications, Fifth Edition (CRC Press), pp. 318-332

  2. Evaluation of Dietary and Alcohol Drinking Patterns in Patients with Excess Body Weight in a Spanish Cohort: Impact on Cardiometabolic Risk Factors

    Nutrients, Vol. 15, Núm. 22

  3. Towards an adiposity-related disease framework for the diagnosis and management of obesities

    Reviews in Endocrine and Metabolic Disorders, Vol. 24, Núm. 5, pp. 795-807

2022

  1. Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease

    Frontiers in Medicine, Vol. 9

  2. Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD

    Scientific Reports, Vol. 12, Núm. 1

  3. ‘Obesities’: Position statement on a complex disease entity with multifaceted drivers

    European Journal of Clinical Investigation, Vol. 52, Núm. 7

2021

  1. Diabetic kidney disease, cardiovascular disease and non-alcoholic fatty liver disease: A new triumvirate?

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  2. Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis

    Clinical Endocrinology, Vol. 94, Núm. 3, pp. 466-472

  3. Role of ANGPTL8 in NAFLD improvement after bariatric surgery in experimental and human obesity

    International Journal of Molecular Sciences, Vol. 22, Núm. 23

2020

  1. The extent of surgery for low-risk 1–4 cm papillary thyroid carcinoma: a catch-22 situation. A retrospective analysis of 497 patients based on the 2015 ATA Guidelines recommendation 35

    Endocrine, Vol. 70, Núm. 3, pp. 538-543

  2. Utilidad del test de TSH recombinante en el seguimiento de pacientes con cáncer diferenciado de tiroides según los resultados de tiroglobulina basal

    Advances in Laboratory Medicine, Vol. 1, Núm. 1

  3. Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results

    Advances in Laboratory Medicine, Vol. 1, Núm. 1

2017

  1. Management of a pregnant woman with thyrotropinoma: a case report and review of the literature

    Gynecological Endocrinology, Vol. 33, Núm. 3, pp. 188-192